Erratum: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients (BMC Cancer (2019) 19 (1061) DOI: 10.1186/s12885-019-6288-7)

Abstract

Following publication of the original article [1], the authors reported an error in Fig. 1f. The representative image of CD34 in cDDP+PIPER tumors (Fig. 1f, at the top-right corner) was inadvertently used incorrectly during the assembly and formatting of the images. The corrected Fig. 1 is presented in this correction article. The authors apologise for the error.